Modulators of epithelial-mesenchymal transitions in prostate cancer: potential for novel therapeutics development

Jinxia Zheng, Ling Li, Holly Russell, Duygu Duzgun, Sebastian Oltean

Open source

DOI
10.3389/fphar.2026.1808307
Published
2026-08-18
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1808307,
  title = {Modulators of epithelial-mesenchymal transitions in prostate cancer: potential for novel therapeutics development},
  author = {Jinxia Zheng and Ling Li and Holly Russell and Duygu Duzgun and Sebastian Oltean},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1808307},
  url = {https://doi.org/10.3389/fphar.2026.1808307}
}

RIS

TY  - JOUR
TI  - Modulators of epithelial-mesenchymal transitions in prostate cancer: potential for novel therapeutics development
AU  - Jinxia Zheng
AU  - Ling Li
AU  - Holly Russell
AU  - Duygu Duzgun
AU  - Sebastian Oltean
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1808307
UR  - https://doi.org/10.3389/fphar.2026.1808307
ER  - 

APA

Zheng, J., Li, L., Russell, H., Duzgun, D., & Oltean, S. (2026). Modulators of epithelial-mesenchymal transitions in prostate cancer: potential for novel therapeutics development. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1808307

Source records